Published Jul 20, 2026, 9:16 AM ET · Updated 4 months ago · 1 source

Acadia gains Fast Track status for remlifanserin in Alzheimer's disease psychosis

Seeking Alpha
Seeking Alpha
·
Original Report

Acadia gains Fast Track status for remlifanserin in Alzheimer's disease psychosis